HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2/Q3 potassium channel activator.

Abstract
KCNQ2 (Kv7.2) and KCNQ3 (Kv7.3) are voltage-gated K(+) channel subunits that underlie the neuronal M current. In humans, mutations in these genes lead to a rare form of neonatal epilepsy (Biervert et al., 1998; Singh et al., 1998), suggesting that KCNQ2/Q3 channels may be attractive targets for novel antiepileptic drugs. In the present study, we have identified the compound N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243) as a selective activator of the neuronal M current and KCNQ2/Q3 channels. In SH-SY5Y human neuroblastoma cells, ICA-27243 produced membrane potential hyperpolarization that could be prevented by coadministration with the M-current inhibitors 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone dihydrochloride (XE-991) and linopirdine. ICA-27243 enhanced both (86)Rb(+) efflux (EC(50) = 0.2 microM) and whole-cell currents in Chinese hamster ovary cells stably expressing heteromultimeric KCNQ2/Q3 channels (EC(50) = 0.4 microM). Activation of KCNQ2/Q3 channels was associated with a hyperpolarizing shift of the voltage dependence of channel activation (V((1/2)) shift of -19 mV at 10 microM). In contrast, ICA-27243 was less effective at activating KCNQ4 and KCNQ3/Q5 and was selective over a wide range of neurotransmitter receptors and ion channels such as voltage-dependent sodium channels and GABA-gated chloride channels. ICA-27243 (1-10 microM) was found to reversibly suppress seizure-like activity in an ex vivo hippocampal slice model of epilepsy and demonstrated in vivo anticonvulsant activity (ED(50) = 8.4 mg/kg) in the mouse maximal electroshock epilepsy model. In conclusion, ICA-27243 represents the first member of a novel chemical class of selective KCNQ2/Q3 activators with anticonvulsant-like activity in experimental models of epilepsy.
AuthorsA D Wickenden, J L Krajewski, B London, P K Wagoner, W A Wilson, S Clark, R Roeloffs, G McNaughton-Smith, G C Rigdon
JournalMolecular pharmacology (Mol Pharmacol) Vol. 73 Issue 3 Pg. 977-86 (Mar 2008) ISSN: 1521-0111 [Electronic] United States
PMID18089837 (Publication Type: Journal Article)
Chemical References
  • Benzamides
  • KCNQ2 Potassium Channel
  • KCNQ3 Potassium Channel
  • N-(6-Chloropyridin-3-yl)-3,4-difluorobenzamide
  • Pyridines
  • RNA, Messenger
Topics
  • Animals
  • Benzamides (pharmacology)
  • CHO Cells
  • Cell Culture Techniques
  • Cell Line
  • Cell Line, Tumor
  • Cricetinae
  • Cricetulus
  • Dose-Response Relationship, Drug
  • Electrophysiology
  • Hippocampus (metabolism)
  • Humans
  • Inhibitory Concentration 50
  • KCNQ2 Potassium Channel (drug effects)
  • KCNQ3 Potassium Channel (drug effects)
  • Kidney (cytology)
  • Male
  • Membrane Potentials (drug effects)
  • Microelectrodes
  • Neuroblastoma (pathology)
  • Patch-Clamp Techniques
  • Plasmids
  • Pyridines (pharmacology)
  • RNA, Messenger (analysis)
  • Rats
  • Rats, Sprague-Dawley
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: